1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions
申请人:Sabila Biosciences LLC
公开号:US10246444B2
公开(公告)日:2019-04-02
Compositions of the invention comprise 1,2-dithiolane, dithiol and related compounds useful as therapeutic agents for the treatment and prevention of diseases and conditions associated with aberrant EGFR activity.